web analytics
0.3 C
Sunday, November 27, 2022

Stock Spotlight on Cannabis Sativa Inc (OTCBB:CBDS)

Cannabis Sativa Inc (OTCBB:CBDS) is making an explosive move up after the Company announced the reorganization of its wholly owned subsidiary, KUSH, as a separate strategic business unit with former United States Senator Mike Gravel at the helm. KUSH will focus on the development and marketing of innovative new cannabis products for the recreational and medicinal markets including a proprietary lozenge called the “Kubby.”

CDBS hit the bb’s in December 2013 at around $0.75 a share and quickly became one of the top most traded stocks on the entire exchange making a spectacular run to highs of $0.18 a share as pot stocks ruled the bb’s. CBDS collapsed with the rest of sector in March after the CANN halt and has been dropping since.

Cannabis Sativa Inc (OTCBB:CBDS) is a holding Company in the post sector with a number of subsidiaries; KUSH is focused on developing natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. Another subsidiary Wild Earth Naturals offers a Skin Garden line of cosmetic products that are developed using organic and natural ingredients, including hemp seed oil.

The shell was incorporated under the laws of the State of Nevada on November 5, 2004 as Ultra Sun Corp. the Company operated a tanning salon business which they ended up selling in September 2013, In November the Company changed their name to Cannabis Sativa, Inc., and a new pot stock was born.

According to CBDS Senator Gravel, the new head of KUSH served as the U.S. Senator for Alaska from 1969 to 1981 and has been an outspoken critic of the failed “War on Drugs” since the Nixon era. Apparently Mr. Gravel is a real maverick in the war on drugs writing several books on the subject. He is also a patient himself and has benefited from its medicinal use.

To Find out the inside Scoop on CBDS Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Cannabis Sativa has had some big names behind it from the beginning; Chairman of the Company Steven Wynn “Steve” Kubby is a Libertarian Party activist who played a key role in the drafting and passage of California Proposition 215, a ballot initiative to legalize medical marijuana which was approved by voters in 1996.

Mr. Kubby himself is a cancer patient and relies on medical MJ. He has written 2 books called the Politics of Consciousness and Why Marijuana Should Be Legal. In the past a number of media outlets reported Mr. Kubby as a felon but his legal statues was resolved on July 3, 2008, when a California Superior Court Judge dismissed all charges against him.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a whopping $103,733,944 million market valuation CBDS has little real fundamentals to back this up with minimal assets including just $40,000 in the treasury and mounting debt that includes $3.5 million in related party payables. Revenues for the 9 months ended September 30, 2014 were just $2,786 compared to $109 last year. This unfortunate financial situation has resulted in significant dilution with OS nearly doubling over the past 12 months from 7,825,000 on November 12, 2013 to 15,033,905 as of November 14, 2014.

At the same time one must not forget that CBDS is a pot stocks with some really big names behind it and a history of getting their brand into the national spotlight. The stock also has a history of big moves and led the sector the last time pot stocks heated up running from $0.75 to $18 a share. Now that we are coming into the season that pot stocks usually heat up CBDS is at the top of many speculators watch lists.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in CBDS either long or short and we have not been compensated for this article.

More articles


Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.